Minimally Invasive Treatments for Benign Prostatic Enlargement
Author Information
Author(s): Lourenco Tania, Pickard Robert, Vale Luke, Grant Adrian, Fraser Cynthia, MacLennan Graeme, N’Dow James
Primary Institution: University of Aberdeen
Hypothesis
To compare the effectiveness and risk profile of minimally invasive interventions against the current standard of transurethral resection of the prostate.
Conclusion
Minimally invasive interventions are less effective than transurethral resection of the prostate but have a better risk profile with fewer adverse events.
Supporting Evidence
- Minimally invasive treatments showed less improvement in symptom scores compared to transurethral resection.
- Rates of reoperation were significantly higher for minimally invasive treatments.
- Minimally invasive interventions had fewer adverse events than transurethral resection.
Takeaway
This study looked at different ways to treat prostate enlargement. Some new methods are easier on the body but don't work as well as the old method.
Methodology
Systematic review and meta-analysis of randomised controlled trials.
Potential Biases
Potential publication bias due to exclusion of unpublished reports.
Limitations
Many studies had small sample sizes and poor quality, and some did not report key data.
Participant Demographics
Participants were men with benign prostatic enlargement, average age around 67 years.
Statistical Information
P-Value
0.004
Confidence Interval
1.27 to 6.53
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website